348 related articles for article (PubMed ID: 32778130)
1. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
[TBL] [Abstract][Full Text] [Related]
2. Patterns of microglial cell activation in frontotemporal lobar degeneration.
Lant SB; Robinson AC; Thompson JC; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Gerhard A; Mann DM
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):686-96. PubMed ID: 24117616
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.
Taipa R; Brochado P; Robinson A; Reis I; Costa P; Mann DM; Melo Pires M; Sousa N
Neurodegener Dis; 2017; 17(4-5):145-154. PubMed ID: 28445885
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
5. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
Sakae N; Roemer SF; Bieniek KF; Murray ME; Baker MC; Kasanuki K; Graff-Radford NR; Petrucelli L; Van Blitterswijk M; Rademakers R; Dickson DW
Ann Clin Transl Neurol; 2019 Sep; 6(9):1782-1796. PubMed ID: 31448566
[TBL] [Abstract][Full Text] [Related]
6. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
7. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
[TBL] [Abstract][Full Text] [Related]
9. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
[TBL] [Abstract][Full Text] [Related]
10. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
[TBL] [Abstract][Full Text] [Related]
11. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
14. MRI signatures of the frontotemporal lobar degeneration continuum.
Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
[TBL] [Abstract][Full Text] [Related]
19. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
